Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
599.00    -5.00 (-0.83%)
Bid:
599.00
Ask:
601.00
Spread: 2.00 (0.334%)
Market Cap: £521.88m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

AGM and Interim Management Statement

7 Feb 2012 07:00

RNS Number : 8868W
Victrex PLC
07 February 2012
 



For Stock Exchange release at 7.00 a.m. Tuesday 7 February 2012

 

Victrex plc

  

AGM and Interim Management Statement

 

At the Annual General Meeting of Victrex plc to be held today, Chairman Anita Frew will make the following statement which comprises Victrex's Interim Management Statement covering the period from 1 October 2011 to date:

  

"We are pleased to announce that, following the de-stocking reported in our Victrex Polymer Solutions business ('VPS') in Q1 of our financial year, Group sales volume for January came back strongly at 288 tonnes (2011: 265 tonnes). This brings the four month total Group sales volume to 870 tonnes.

 

We remain mindful of the continuing economic uncertainty and the impact it may have on VPS sales volume for the full year. However, the current order book for February and new business development activity are encouraging.

 

Our Invibio Biomaterial Solutions business has made a solid start to the financial period and we continue to expect growth for the year.

 

There have been no significant changes in the financial position of the Company since 30 September 2011 and the Group remains in an excellent financial position with a healthy balance sheet and strong cash generation.

 

Our capacity expansion plans are on track and we continue to invest in new application development and technical leadership to ensure we capitalise on the growth potential for our business."

 

 

 

 

Victrex will host a conference call at 8.00 a.m. today for analysts. If you would like more details, please contact Naomi Lane at MHP on 0203 128 8204 / Naomi.Lane@mhpc.com.

 

The Group will also hold an investor day for institutional investors and analysts in London tomorrow, Wednesday 8 February, focusing on its VPS division. No new trading or price sensitive information will be disclosed. A copy of the presentation will be made available on Victrex's website following the event.

 

Victrex will provide a trading update for the six months to 31 March 2012 on Thursday 5 April 2012.

 

 

Enquiries

 

Victrex plc

Anita Frew, Chairman 0203 128 8100 (7 February 2012)

David Hummel, Chief Executive 01253 897700 (thereafter)

Steve Barrow, Finance Director

 

MHP Communications

Nick Denton / Barnaby Fry / Ian Payne 0203 128 8100

 

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK polymer, a high performance, easy to process thermoplastic.

 

With over 30 years of experience, Victrex is a provider of innovative, high performance thermoplastic polymers. We work with customers and end users globally to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions business unit ('VPS') focuses on our transport, industrial and electronics markets and our Invibio® Biomaterial Solutions business unit ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMDMGGZKVGGZZM
Date   Source Headline
16th Dec 20154:37 pmRNSDirector/PDMR Shareholding
15th Dec 201512:03 pmRNSDirector/PDMR Shareholding
9th Dec 20152:34 pmRNSDirector/PDMR Shareholding
8th Dec 20154:43 pmRNSHolding(s) in Company
8th Dec 20157:00 amRNSFinal Results
4th Dec 20154:07 pmRNSHolding(s) in Company
1st Dec 20154:49 pmRNSHolding(s) in Company
1st Dec 20152:54 pmRNSBlocklisting Interim Review
30th Nov 20153:39 pmRNSTotal Voting Rights
20th Nov 20154:04 pmRNSHolding(s) in Company
17th Nov 20154:08 pmRNSDirector/PDMR Shareholding
30th Oct 201510:32 amRNSTotal Voting Rights
19th Oct 20153:13 pmRNSDirector/PDMR Shareholding
8th Oct 20157:00 amRNSTrading Statement
30th Sep 20151:56 pmRNSTotal Voting Rights
29th Sep 20154:19 pmRNSDirectorate Change
28th Sep 20154:28 pmRNSDirector/PDMR Shareholding
24th Sep 201511:50 amRNSDirector/PDMR Shareholding
21st Sep 201511:42 amRNSHolding(s) in Company
17th Sep 201511:23 amRNSDirector/PDMR Shareholding
28th Aug 201512:06 pmRNSTotal Voting Rights
26th Aug 20154:24 pmRNSHolding(s) in Company
18th Aug 20152:12 pmRNSDirector/PDMR Shareholding
31st Jul 20154:09 pmRNSTotal Voting Rights
31st Jul 20152:24 pmRNSHolding(s) in Company
31st Jul 201512:08 pmRNSDirectorate Change
21st Jul 20157:00 amRNSInterim Management Statement
20th Jul 20159:58 amRNSDirector/PDMR Shareholding
30th Jun 20153:38 pmRNSTotal Voting Rights
26th Jun 201511:07 amRNSDirector Declaration
17th Jun 20154:06 pmRNSDirector/PDMR Shareholding
1st Jun 20153:52 pmRNSBlocklisting Interim Review
29th May 201510:00 amRNSTotal Voting Rights
26th May 20154:39 pmRNSDirector/PDMR Shareholding
19th May 20153:58 pmRNSDirector/PDMR Shareholding
19th May 20159:52 amRNSVictrex first half pretax profit jumps 10%
19th May 20157:00 amRNSHalf Yearly Report
11th May 20154:31 pmRNSHolding(s) in Company
6th May 20154:34 pmRNSHolding(s) in Company
30th Apr 20152:30 pmRNSTotal Voting Rights
28th Apr 20154:34 pmRNSHolding(s) in Company
21st Apr 20157:00 amRNSCapital Markets Day
20th Apr 20153:23 pmRNSDirector/PDMR Shareholding
9th Apr 20157:00 amRNSTrading Statement
31st Mar 20153:25 pmRNSTotal Voting Rights
26th Mar 20153:20 pmRNSDirectorate Change
23rd Mar 20157:00 amRNSDirectorate Change
19th Mar 20154:32 pmRNSHolding(s) in Company
17th Mar 20152:28 pmRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.